1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow VMBP protocol: new trials by email Literature Review of VMBP protocol trials Research Report on VMBP protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma Batiraxcept, Cabozantinib (Cabo), Nivolumab - Clear Cell Renal Cell Carcinoma | Phase 1 / Phase 2 | Terminated | Aravive, Inc. | 72 | 2021-02-26 | 2023-10-30 |
Carcinoma, Renal Cell (1) · Kidney Diseases (1) · Kidney Neoplasms (1) · Urologic Neoplasms (1)
Aravive, Inc. (1)
United States (1)